To gain evidence about the role of ILK in CKD-associated vascular damage and to test the possibility that smooth muscle cells could be one of the targets of uremic toxins in the development of vascular fibrosis, we decided to perform in vitro experiments with human aortic vascular smooth muscle cells, HA-VSMC. The gene discussed is ILK; the disease is chronic kidney disease.